Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
UGA Biopharma provides high speed Cell Line Development services for new Biological Drug Candidates, services for Biosimilar Development and a high performance First CHOice® cell culture medium and feeds. A large number of development projects were successfully completed for example: Bevacizumab (AVASTIN®), Eculizumab (SOLIRIS®), Darbepoetin alfa (ARANESP®), Nivolumab (OPDIVO®)...